3,3'-diindolylmethane inhibits prostate cancer development in the transgenic adenocarcinoma mouse prostate model

Molecular Carcinogenesis

Volumn 50, Issue 2, 2011, Pages 100-112

  Cho, Han Jin ^a   Park, So Young ^a   Kim, Eun Ji ^a   Kim, Jin Kyung ^a   Park, Jung Han Yoon ^a  

^a Hallym University   (South Korea)

Author keywords

Apoptosis; Caspase; DIM; Fas; Prostate cancer; TRAMP

Indexed keywords

3,3' DIINDOLYLMETHANE; CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; CYCLIN A; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYTOCHROME C; FAS ANTIBODY; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN P27; TUMOR ANTIGEN;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE ARREST; CONTROLLED STUDY; FEMALE; MALE; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SIMIAN VIRUS 40;

ADENOCARCINOMA; ANIMALS; ANTICARCINOGENIC AGENTS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; APOPTOSIS; BCL-X PROTEIN; CARRIER PROTEINS; CASPASES; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN A; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYTOCHROMES C; DISEASE MODELS, ANIMAL; HUMANS; INDOLES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOCHONDRIAL MEMBRANES; MITOCHONDRIAL PROTEINS; OLIGOPEPTIDES; PEPTIDES; PERMEABILITY; POLY(ADP-RIBOSE) POLYMERASES; PROLIFERATING CELL NUCLEAR ANTIGEN; PROSTATIC NEOPLASMS; PROTEIN TRANSPORT;

MUS;

EID: 78651430467     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20698     Document Type: Article

References (46)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96.
2. Jones RA, Underwood SM, Rivers BM. Reducing prostate cancer morbidity and mortality in African American men: Issues and challenges. Clin J Oncol Nurs 2007; 11: 865-872.
3. Chan JM, Stampfer MJ, Giovannucci E, et al. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study. Science 1998; 279: 563-566.
4. Jain MG, Hislop GT, Howe GR, Ghadirian P. Plant foods, antioxidants, and prostate cancer risk: Findings from case-control studies in Canada. Nutr Cancer 1999; 34: 173-184.
5. Cohen JH, Kristal AR, Stanford JL. Fruit and vegetable intakes and prostate cancer risk. J Natl Cancer Inst 2000; 92: 61-68.
6. Kolonel LN, Hankin JH, Whittemore AS, et al. Vegetables, fruits, legumes and prostate cancer: A multiethnic case-control study. Cancer Epidemiol Biomarker Prev 2000; 9: 795-804.
7. Bradfield CA, Bjeldanes LF. High-performance liquid chromatographic analysis of anticarcinogenic indoles in Brassica oleracea. J Agric Food Chem 1987; 35: 46-49.
8. Sarkar FH, Li Y. Indole-3-carbinol and prostate cancer. J Nutr 2004; 134: 3493S-3498S.
9. De Kruif CA, Marsman JW, Venekamp JC, et al. Structure elucidation of acid reaction products of indole-3-carbinol: Detection in vivo and enzyme induction in vitro. Chem Biol Interact 1991; 80: 303-315.
10. Vivar OI, Lin CL, Firestone GL, Bjeldanes LF. 3, 3'-Diindolylmethane induces a G(1) arrest in human prostate cancer cells irrespective of androgen receptor and p53 status. Biochem Pharmacol 2009; 78: 469-476.
11. Nachshon-Kedmi M, Yannai S, Fares FA. Induction of apoptosis in human prostate cancer cell line, PC3, by 3, 3'-diindolylmethane through the mitochondrial pathway. Br J Cancer 2004; 91: 1358-1363.
12. Nachshon-Kedmi M, Yannai S, Haj A, Fares FA. Indole-3-carbinol and 3, 3'-diindolylmethane induce apoptosis in human prostate cancer cells. Food Chem Toxicol 2003; 41: 745-752.
13. Ashkenazi A, Dixit VM. Death receptors: Signaling and modulation. Science 1998; 281: 1305-1308.
14. Vander Heiden MG, Thompson CB. Bcl-2 proteins: Regulators of apoptosis or of mitochondrial homeostasis? Nat Cell Biol 1999; 1: E209-E216.
15. Nachshon-Kedmi M, Fares FA, Yannai S. Therapeutic activity of 3, 3'-diindolylmethane on prostate cancer in an in vivo model. Prostate 2004; 61: 153-160.
16. Killion JJ, Radinsky R, Fidler IJ. Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer Metastasis Rev 1998; 17: 279-284.
17. Greenberg NM, DeMayo F, Finegold MJ, et al. Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 1995; 92: 3439-3443.
18. Gingrich JR, Barrios RJ, Morton RA, et al. Metastatic prostate cancer in a transgenic mouse. Cancer Res 1996; 56: 4096-4102.
19. Rokhlin OW, Bishop GA, Hostager BS, et al. Fas-mediated apoptosis in human prostatic carcinoma cell lines. Cancer Res 1997; 57: 1758-1768.
20. Bookstein R, Shew JY, Chen PL, Scully P, Lee WH. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science 1990; 247: 712-715.
21. Rokhlin OW, Gudkov AV, Kwek S, Glover RA, Gewies AS, Cohen MB. p53 is involved in tumor necrosis factor-alpha-induced apoptosis in the human prostatic carcinoma cell line LNCaP. Oncogene 2000; 19: 1959-1968.
22. Greenberg NM, DeMayo FJ, Sheppard PC, et al. The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice. Mol Endocrinol 1994; 8: 230-239.
23. Gingrich JR, Barrios RJ, Foster BA, Greenberg NM. Pathologic progression of autochthonous prostate cancer in the TRAMP model. Prostate Cancer Prostatic Dis 1999; 2: 70-75.
24. Jung JI, Lim SS, Choi HJ, et al. Isoliquiritigenin induces apoptosis by depolarizing mitochondrial membranes in prostate cancer cells. J Nutr Biochem 2006; 17: 689-696.
25. Cho HJ, Kim WK, Kim EJ, et al. Conjugated linoleic acid inhibits cell proliferation and ErbB3 signaling in HT-29 human colon cell line. Am J Physiol 2003; 284: G996-G1005.
26. Eguchi Y, Srinivasan A, Tomaselli KJ, Shimizu S, Tsujimoto Y. ATP-dependent steps in apoptotic signal transduction. Cancer Res 1999; 59: 2174-2181.
27. Koll H, Guiard B, Rassow J, et al. Antifolding activity of hsp60 couples protein import into the mitochondrial matrix with export to the intermembrane space. Cell 1992; 68: 1163-1175.
28. Tokuyama Y, Reddy AP, Bethea CL. Neuroprotective actions of ovarian hormones without insult in the raphe region of rhesus macaques. Neuroscience 2008; 154: 720-731.
29. Kaplan-Lefko PJ, Chen TM, Ittmann MM, et al. Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model. Prostate 2003; 55: 219-237.
30. Rahman KM, Banerjee S, Ali S, et al. 3, 3'-Diindolylmethane enhances taxotere-induced apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation. Cancer Res 2009; 69: 4468-4475.
31. Smiley ST, Reers M, Mottola-Hartshorn C, et al. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc Natl Acad Sci USA 1991; 88: 3671-3675.
32. Souli E, Machluf M, Morgenstern A, Sabo E, Yannai S. Indole-3-carbinol (I3C) exhibits inhibitory and preventive effects on prostate tumors in mice. Food Chem Toxicol 2008; 46: 863-870.
33. Hong C, Firestone GL, Bjeldanes LF. Bcl-2 family-mediated apoptotic effects of 3, 3'-diindolylmethane (DIM) in human breast cancer cells. Biochem Pharmacol 2002; 63: 1085-1097.
34. Gross A, Jockel J, Wei MC, Korsmeyer SJ. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J 1998; 17: 3878-3885.
35. Chen L, Park SM, Tumanov AV, et al. CD95 promotes tumour growth. Nature 465: 492-496.
36. Peter ME, Budd RC, Desbarats J, et al. The CD95 receptor: Apoptosis revisited. Cell 2007; 129: 447-450.
37. Krammer PH. CD95's deadly mission in the immune system. Nature 2000; 407: 789-795.
38. Nagata S. Apoptosis by death factor. Cell 1997; 88: 355-365.
39. Abdelrahim M, Newman K, Vanderlaag K, Samudio I, Safe S. 3, 3'-Diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5. Carcinogenesis 2006; 27: 717-728.
40. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008; 454: 436-444.
41. Mantovani A. Cancer: Inflaming metastasis. Nature 2009; 457: 36-37.
42. Cho HJ, Seon MR, Lee YM, et al. 3, 3'-Diindolylmethane suppresses the inflammatory response to lipopolysaccharide in murine macrophages. J Nutr 2008; 138: 17-23.
43. Kim YH, Kwon HS, Kim DH, et al. 3, 3'-Diindolylmethane attenuates colonic inflammation and tumorigenesis in mice. Inflamm Bowel Dis 2009; 15: 1164-1173.
44. Anderton MJ, Manson MM, Verschoyle R, et al. Physiological modeling of formulated and crystalline 3, 3'-diindolylmethane pharmacokinetics following oral administration in mice. Drug Metab Dispos 2004; 32: 632-638.
45. Cartea ME, Velasco P, Obregon S, Padilla G, de Haro A. Seasonal variation in glucosinolate content in Brassica oleracea crops grown in northwestern Spain. Phytochemistry 2008; 69: 403-410.
46. Cieslik E, Leszczynska T, Filipiak-Florkiewicz A, Sikora E, Pisulewski PM. Effects of some technological processes on glucosinolate contents in cruciferous vegetables. Food Chem 2007; 105: 976-981.